Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Viagra Articles

Merck Files NDA For Oral Impotence Drug

10 September 1997

Pfizer Enters New Product Cycle With Strong Potential

7 August 1997

Strength In Astra's R&D To Cushion Losec's Demise?

9 June 1997

Oral Impotence Therapy Effective In Phase III Trial

30 May 1997

New York Stock Comment

3 March 1997

Zoloft Gets OCD Indication

4 November 1996

Pfizer's Impotence Pill Shows Promise

13 May 1996

Showing 501-507 of 507 articles

Go to beginningPrevious
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
NextGo to end
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Pfizer to split-off remaining 80% interest in Zoetis
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Pfizer to split-off remaining 80% interest in Zoetis

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS